Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis

Cancer Research

Volumn 62, Issue 4, 2002, Pages 1030-1035

  Wu, Yiping ^a   Yakar, Shoshana ^a   Zhao, Ling ^a   Hennighausen, Lothar ^a   LeRoith, Derek ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT SOMATOMEDIN C; SODIUM CHLORIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CANCER GROWTH; CECUM TUMOR; COLON ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; CECAL NEOPLASMS; CELL DIVISION; COLONIC NEOPLASMS; FEMALE; INSULIN-LIKE GROWTH FACTOR I; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RECEPTOR, IGF TYPE 1; RECOMBINANT PROTEINS;

EID: 0036173548     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression
2. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice
3. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3
4. Circulating concentrations of insulinlike growth factor-I and risk of breast cancer
5. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
6. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
7. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis
8. High-risk colorectal adenomas and serum insulin-like growth factors
9. Acromegaly, colonic polyps and carcinoma
10. Normal growth and development in the absence of hepatic insulin-like growth factor I
11. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: Manipulation using the Cre/IoxP system in transgenic mice
12. Protocols for screening chemical agents and natural products against animal tumors and other biological systems
13. Rapid development of hepatic metastasis with high incidence following orthotopic transplantation of murine colon 38 carcinoma as intact tissue in syngeneic C57BL/6 mice
14. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins in bovine sera and pituitaries at different stages of the estrous cycle
15. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
16. Insulin-like growth factor-binding protein enhancement of insulinlike growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line
17. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I
18. Induction of vascular endothelial growth factor by insulin-like growth factor I in colorectal carcinoma
19. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells
20. Molecular and biological properties of the vascular endothelial growth factor family of proteins
21. Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro
22. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
23. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
24. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma
25. In oesophageal squamous cell carcinoma, vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis
26. Quantitative analysis of vascular endothelial growth factor in primary breast cancer
27. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
28. Immunotherapy of tumors expressing Igf-I
29. Does recombinant human insulin-like growth factor-I have a role in the treatment of diabetes?
30. Effects of growth hormone and insulin-like growth factor I on renal growth and function
31. Growth hormone therapy for protein catabolism
32. Role of IGF-1 in muscular atrophy of aging
33. Antibody to type I insulin like growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice
34. Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice
35. Synthesis and biological evaluation of antagonists of growth hormonereleasing hormone with high and protracted in vivo activities